Kriptofix Chelators for Selective Heavy Metal Removal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current chelate-forming compounds for heavy metal poisoning, such as EDTA and strontium-specific cryptand derivatives, are not specific enough, leading to the removal of essential metals like calcium and magnesium, and have stability and solubility issues, which reduces their effectiveness and increases storage and preparation costs for emergency situations.

Innovation Solution

Development of complex-forming compounds with a KRIPTOFIX base structure, specifically designed to selectively bind strontium, lead, and tin ions, with enhanced water solubility and stability, minimizing the risk of decarboxylation to toxic compounds, and avoiding the removal of essential metals like zinc and copper.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional chelate-forming compounds like EDTA are used, then metal ions can be removed from the body, but essential metals like calcium and magnesium are also removed due to lack of specificity

Engineering Contradiction:
Improvemetal ion removalVSAvoidremoval of essential metals
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by designing the chelating agent with specific macrocyclic cavity sizes and functional group arrangements that create localized binding environments tailored to match the ionic radius and coordination geometry of toxic metal ions (Sr2+, Pb2+, Hg2+) while excluding essential metals like Ca2+ and Mg2+. This structural specificity ensures selective binding at the molecular level.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs parameter changes by systematically varying the macrocyclic ring size, number of donor atoms, and spacing of chelating groups to optimize the stability constants for different toxic metal ions. By adjusting these structural parameters, the compound achieves significantly higher binding affinity for toxic metals compared to essential metals, resolving the selectivity issue.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If macrocyclic compounds with high selectivity for strontium are used, then strontium can be removed selectively, but the compounds have stability issues and decarboxylate to toxic compounds

Engineering Contradiction:
Improveselective strontium removalVSAvoidcompound stability
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies the taking out principle by removing the unstable malonic acid substructure from the molecule and replacing it with more stable carboxylate groups that maintain chelating functionality. This extraction of the problematic structural element eliminates the decarboxylation pathway while preserving the ability to form stable complexes with strontium and other toxic metal ions.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent converts the potential harm of decarboxylation into a benefit by designing a structure where the carboxylate groups are positioned and protected in a way that enhances complex stability. The macrocyclic framework itself provides stability that prevents decomposition, and the chelating groups are optimized to form so stable complexes that decomposition pathways are suppressed.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Quantity of substance

If high doses of chelating compounds are administered, then toxic metal ions can be effectively removed, but the burden on the organism increases

Engineering Contradiction:
Improvetoxic metal ion removalVSAvoidburden on organism
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent achieves dramatically improved binding affinity through optimization of the stability constant parameter. The macrocyclic structure with optimized donor atom arrangement creates extremely stable complexes with toxic metal ions, with stability constants several orders of magnitude higher than conventional chelators. This enhanced binding strength allows effective metal ion removal at much lower dosages, reducing the metabolic burden on the organism.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new compounds demonstrate significantly improved selectivity and efficacy in binding strontium and other toxic ions, reducing the required dosage by a fourth, minimizing the burden on the organism, and forming non-toxic degradation products, thus offering a more effective and cost-efficient solution for heavy metal removal.

Implementation Method 1

complex-forming compounds with a KRIPTOFIX base structure, specifically designed to selectively bind strontium, lead, and tin ions

Methodology Applied
Scientific EffectChelation: Chemical Bonding

Data Source

PatentEP2797900B1Complex-forming compounds
Publication Date: 2016.09.28 STRATOXERS KFT
  • EP2797900B1 patent drawingFigure 1-A~1-B
  • EP2797900B1 patent drawingFigure 2-A~2-B
  • EP2797900B1 patent drawingFigure 3-A~3-B

AI summary

Present invention refers to complex-forming compounds of the general formula and the use and preparation thereof.